Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Mar-24 7:39 PM View:  | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 6,162 | $1.20 | $7,394.40 | (2%) 404.92K to 398.76K | |
| 04-Mar-24 7:39 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 27,687 | $1.17 | $32,393.80 | (6%) 432.61K to 404.92K | |
| 29-Feb-24 5:35 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 188,205 | -- | -- | 77% 244.4K to 432.61K | |
| 29-Feb-24 5:35 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 27-Feb-24 | Sale | 2,545 | $1.32 | $3,369.07 | (1%) 246.94K to 244.4K | |
| 08-Feb-24 4:36 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 06-Feb-24 | Sale | 4,205 | $1.59 | $6,671.23 | (2%) 251.15K to 246.94K | |
| 25-Jan-24 6:47 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 13,333 | -- | -- | 6% 237.82K to 251.15K | |
| 05-Sep-23 4:30 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 01-Sep-23 | Sale | 6,913 | $1.33 | $9,203.28 | (3%) 244.73K to 237.82K | |
| 05-Jun-23 4:10 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 02-Jun-23 | Sale | 631 | $2.22 | $1,400.82 | (< 1%) 245.36K to 244.73K | |
| 02-Mar-23 5:30 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-23 | Sale | 11,205 | $3.03 | $33,942.20 | (4%) 256.57K to 245.36K | |
| 02-Mar-23 5:30 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-23 | Grant | 95,000 | -- | -- | 59% 161.57K to 256.57K | |
| 01-Mar-23 4:05 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 27-Feb-23 | Sale | 2,802 | $3.04 | $8,509.11 | (2%) 164.37K to 161.57K | |
| 08-Feb-23 4:11 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 06-Feb-23 | Sale | 4,141 | $3.40 | $14,079.40 | (2%) 168.51K to 164.37K | |
| 01-Sep-22 8:59 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 31-Aug-22 | Grant | 30,000 | -- | -- | 22% 138.51K to 168.51K | |
| 06-Jun-22 5:40 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 03-Jun-22 | Market Sale | 601 | $6.04 | $3,630.12 | (< 1%) 139.11K to 138.51K | 2% |
| 02-Mar-22 3:33 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-22 | Grant | 88,200 | -- | -- | 165% 53.31K to 141.51K | |
| 02-Mar-22 3:33 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-22 | Sale | 2,398 | $10.24 | $24,549.50 | (2%) 141.51K to 139.11K | |
| 09-Feb-22 5:25 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 07-Feb-22 | Private Sale | 3,947 | $9.86 | $38,925.30 | (7%) 57.26K to 53.31K | |
| 01-Jun-21 5:53 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 01-Jun-21 | Grant | 5,500 | -- | -- | 11% 51.76K to 57.26K | |
| 01-Mar-21 8:16 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 25-Feb-21 | Grant | 22,013 | -- | -- | 74% 29.74K to 51.76K | |
| 17-Feb-21 6:46 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 11-Feb-21 | Market Sale | 2,858 | $15.52 | $44,353.60 | (35%) 8.15K to 5.29K | 3% |
| 09-Feb-21 8:32 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 05-Feb-21 | Option Exercise | 8,150 | -- | -- | 100% 0 to 8.15K | |
| 14-Aug-18 6:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Aug-18 | Grant | 1,012 | -- | -- | 367% 0.28K to 1.29K | |
| 14-Aug-18 6:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Aug-18 | Payment of Exercise | 449 | $90.95 | $40,836.50 | (35%) 1.29K to 0.84K | 8% |
| 14-Aug-18 6:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Jul-18 | Acquisition (other) | 23 | -- | -- | 9% 0.25K to 0.28K | |
| 14-Aug-18 6:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Apr-18 | Acquisition (other) | 22 | -- | -- | 10% 0.23K to 0.25K | |
| 14-Aug-18 6:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 17-Jan-18 | Acquisition (other) | 5 | -- | -- | 2% 0.23K to 0.23K | |
| 08-Jan-18 5:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Jan-18 | Option Exercise | 31,781 | $88.26 | $2,804,910.00 | 612% 5.19K to 36.97K | |
| 08-Jan-18 5:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Jan-18 | Market Option Sale (Planned) | 31,781 | $131.59 | $4,181,970.00 | (86%) 36.97K to 5.19K | 37% |
| 08-Jan-18 5:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Jan-18 | Market Sale (Planned) | 4,964 | $131.59 | $653,199.00 | (96%) 5.19K to 0.23K | 37% |
| 03-Jan-18 5:26 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 30-Dec-17 | Payment of Exercise | 3,538 | $127.05 | $449,503.00 | (41%) 8.73K to 5.19K | 34% |
| 03-Jan-18 5:26 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 30-Dec-17 | Option Exercise | 8,502 | -- | -- | 3762% 0.23K to 8.73K | |
| 09-Feb-18 10:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Sep-17 | Disposition | 1,950 | $115.47 | $225,166.00 | (90%) 2.18K to 0.23K | 28% |
| 17-May-17 6:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-May-17 | Option Exercise | 9,375 | $14.04 | $131,588.00 | 431% 2.18K to 11.55K | |
| 17-May-17 6:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-May-17 | Market Option Sale (Planned) | 9,375 | $70.00 | $656,250.00 | (81%) 11.55K to 2.18K | (19%) |
| 03-Jun-15 4:33 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Jun-15 | Option Exercise | 4,791 | $46.03 | $220,526.00 | 239% 2.01K to 6.8K | |
| 03-Jun-15 4:33 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Jun-15 | Market Option Sale (Planned) | 4,791 | $131.84 | $631,646.00 | (70%) 6.8K to 2.01K | 37% |
| 16-Dec-14 7:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Dec-14 | Option Exercise | 20,625 | $11.50 | $237,117.00 | 585% 3.52K to 24.15K | |
| 16-Dec-14 7:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Dec-14 | Market Option Sale (Planned) | 20,625 | $97.50 | $2,010,950.00 | (85%) 24.15K to 3.52K | 14% |
| 16-Dec-14 7:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Dec-14 | Market Sale (Planned) | 1,537 | $97.50 | $149,858.00 | (44%) 3.52K to 1.99K | 14% |
| 04-Feb-14 5:51 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Feb-14 | Market Sale (Planned) | 3,750 | $78.66 | $294,992.00 | (52%) 7.19K to 3.44K | (6%) |
| 27-Jan-14 4:46 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 23-Jan-14 | Payment of Exercise | 2,560 | $89.49 | $229,094.00 | (26%) 9.75K to 7.19K | 7% |
| 18-Dec-13 7:26 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Dec-13 | Option Exercise | 8,000 | $12.56 | $100,510.00 | 82% 9.75K to 17.75K | |
| 18-Dec-13 7:26 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Dec-13 | Market Option Sale (Planned) | 8,000 | $60.36 | $482,872.00 | (45%) 17.75K to 9.75K | (38%) |
| 04-Dec-13 5:01 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Dec-13 | Option Exercise | 3,750 | $7.10 | $26,625.00 | 38% 9.75K to 13.5K | |
| 04-Dec-13 5:01 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Dec-13 | Market Option Sale (Planned) | 3,750 | $61.83 | $231,863.00 | (28%) 13.5K to 9.75K | (35%) |
| 12-Jul-13 5:44 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Jul-13 | Option Exercise | 14,200 | $31.39 | $445,738.00 | 147% 9.67K to 23.87K | |
| 12-Jul-13 5:44 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Jul-13 | Market Option Sale (Planned) | 14,200 | $50.00 | $710,000.00 | (59%) 23.87K to 9.67K | (67%) |
| 02-Jul-13 5:32 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Jul-13 | Option Exercise | 27,000 | $22.13 | $597,450.00 | 279% 9.67K to 36.67K | |
| 02-Jul-13 5:32 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Jul-13 | Market Option Sale (Planned) | 27,000 | $32.00 | $864,000.00 | (74%) 36.67K to 9.67K | (161%) |
| 19-Jun-13 5:34 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 17-Jun-13 | Option Exercise | 23,625 | $13.64 | $322,202.00 | 244% 9.67K to 33.29K |